Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000481808 | SCV000568831 | likely pathogenic | not provided | 2018-10-11 | criteria provided, single submitter | clinical testing | The P387L variant in the SQSTM1 gene has been reported in individuals with Paget disease of bone as well as inindividuals with frontotemporal dementia (Johnson-Pais et al., 2003; Gennari et al., 2010; Le Ber et al., 2013; vander Zee et al., 2014). In vitro studies demonstrate that the P387L results in decreased binding of monoubiquitin andpolyubiquitin as compared to wild-type (Cavey et al., 2006). The P387L variant was not observed in approximately6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating itis not a common benign variant in these populations. The P387L variant is a semi-conservative amino acidsubstitution, which may impact secondary protein structure as these residues differ in some properties and occurs at aposition that is conserved across species. The P387L variant is a strong candidate for a pathogenic variant, howeverthe possibility it may be a rare benign variant cannot be excluded. |
| Invitae | RCV001323701 | SCV001514628 | uncertain significance | Frontotemporal dementia and/or amyotrophic lateral sclerosis 1; Paget disease of bone 2, early-onset | 2023-10-05 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 387 of the SQSTM1 protein (p.Pro387Leu). This variant is present in population databases (rs776749939, gnomAD 0.03%). This missense change has been observed in individual(s) with Paget disease, frontotemporal dementia or dementia (PMID: 14584883, 20200946, 22972638, 24042580, 24899140, 25796131, 29525180). ClinVar contains an entry for this variant (Variation ID: 202211). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SQSTM1 protein function. Experimental studies have shown that this missense change affects SQSTM1 function (PMID: 16691492, 17229008). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| OMIM | RCV000184065 | SCV000236599 | pathogenic | Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 | 2014-09-01 | no assertion criteria provided | literature only |